Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 216-341-5 | CAS number: 1561-92-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD protocl study under GLP; no deviations
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Sodium 2-methylprop-2-ene-1-sulphonate
- EC Number:
- 216-341-5
- EC Name:
- Sodium 2-methylprop-2-ene-1-sulphonate
- Cas Number:
- 1561-92-8
- Molecular formula:
- C4H8O3S.Na
- IUPAC Name:
- sodium 2-methylprop-2-ene-1-sulfonate
- Test material form:
- solid: crystalline
- Details on test material:
- - Name of test material (as cited in study report): natriummethallylsulfonat
- Substance type: organic
- Physical state: solid crystalline
- Analytical purity: 99.8 %
- Impurities (identity and concentrations):
- Composition of test material, percentage of components: < 0.2% water. 0.05% naCl
- Isomers composition:
- Purity test date: Oct 1989
- Lot/batch No.: unknown
- Expiration date of the lot/batch: undeterminate
- Stability under test conditions: stable
- Storage condition of test material: Normal lab conditions
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: BOR:NMRI (SPF Harlan)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Fa Winkelmann, 4799 Borchem , Germany
- Age at study initiation: young adult mice
- Weight at study initiation: male 23.3 +- 0.9 ; female 23.5 +- 0.7
- Assigned to test groups randomly: [no/yes, under following basis: ] yes
- Fasting period before study: 18 hrs
- Housing: sex-separated, 5 anmials / Makrolon cage type III
- Diet (e.g. ad libitum): Saniff R10, Fa. Sniff 4770, Soest
- Water (e.g. ad libitum): ad lib
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 C +-1
- Humidity (%): 60 %+- 10
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: within lab: from 19-04-1990 to 28-09-1990
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- aqua bidest
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
- Duration of treatment / exposure:
- 24, 48 and 72 hrs
- Frequency of treatment:
- single dose
- Post exposure period:
- None
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
1250 mg/kg bw
Basis:
actual ingested
dose determined on the basis of body weight immediately prior to dosing
- Remarks:
- Doses / Concentrations:
2500 mg/kg bw
Basis:
actual ingested
dose determined on the basis of body weight immediately prior to dosing
- Remarks:
- Doses / Concentrations:
5000 mg/kg bw
Basis:
actual ingested
dose determined on the basis of body weight immediately prior to dosing
- No. of animals per sex per dose:
- 5 / 5
- Control animals:
- yes
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide;
- Justification for choice of positive control(s): Known positive, historical data available
- Route of administration: oral gavage
- Doses / concentrations: 100 mg/kg bw
Examinations
- Tissues and cell types examined:
- 1000 polychromatic erythrocytes / animal
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: dose-range finding with 5000, 6500, 7500 and 10000 mg/kg bw established confirmed highest LD (zero) of 5000 mg/kg bw
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
after preparation of both femurs, the bone marrow is washed out using fetal bovine serum and a syringe. the cell suspension was centrifuged for 5 minutes at 160 g, then decanted and re-suspended. This suspension was cleaned by means of a cellulose chromatography tube.
The eluate from the tube was centrifuged (10 min/800 g) , the pellet was re-suspended in fetal bovine serum with 25mM EDTA.
DETAILS OF SLIDE PREPARATION:
From this suspension, 3-4 slides were prepared, dried for 24 hrs and colored with May-Gruenwald / Giemsa solution
METHOD OF ANALYSIS:
100-fold enlargement, Zeiss Microscope
1000 PCE cells/. animals
number of PCE cells with micronuclei
PCE /NCE determined
number of NCE cells with micronuclei . - Evaluation criteria:
- Positive if a statistically significant increase in the frequency of micronucleus-containing PCE is found in at least one test group relatie to the neagative controls
- Statistics:
- Not specified
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- discolored feces (all animals and mild diarrhea in males
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 500, 6500, 7500, 10000 mg/kg bw
- Solubility: 750 g/l
- Clinical signs of toxicity in test animals: sedation and 1/3 fatality in 6500 group, sedation and 1 / 5 fatalties in teh 7500 group, sedation and 3/ /5 fatalities in the 10000 group.
- Harvest times: 24, 48, 72 hrs
RESULTS OF DEFINITIVE STUDY
- Induction of micronuclei (for Micronucleus assay): see table
- Ratio of PCE/NCE (for Micronucleus assay): see tabel
- Appropriateness of dose levels and route: route is appropriate in view of exposure potential; dose: you can't go much higher, can you?.
- Statistical evaluation: see table.
Any other information on results incl. tables
Testgruppe |
Dosis |
Entnahme nach |
% PCE mit |
PCE/NCE |
|
(mg/kg KG) |
Appl. (in h) |
MK (x ± SD) |
(x ± SD) |
Positivkontrolle |
|
|
|
|
(Cyclophosphamid) |
100 |
24 |
* 3,95 ± 1,37 |
* 0,48 ± 0,2 |
|
_ |
24 |
0,07 ± 0,05 |
1,13 ± 0,2 |
Negativkontrolle |
|
|
|
|
(Wasser) |
- |
48 |
0,25 ± 0,12 |
1,31 ± 0,09 |
|
- |
72 |
0,28 ± 0,10 |
1,20 ± 0,33 |
|
5000 |
24 |
0,09 ± 0,06 |
0,97 ± 0,2 |
NATRIUM |
|
|
|
|
METHALLYL |
5000 |
48 |
0,18 ± 0,08 |
1,26 ± 0,16 |
SULFONAT |
|
|
|
|
(Gruppe I) |
5000 |
72 |
0,18 ± 0,11 |
1,38 ± 0,20 |
MAS-Na (Gruppe II) |
2500 |
24 |
0,13 ± 0,06 |
1,10 ± 0,3 |
MAS-Na (Gruppe III) |
1250 |
24 |
0,05 ± 0,05 |
1,20 ± 0,2 |
* statistisch signifikante Veranderung gegenüber der Negativkontrolle (Vertrauensbereich = 95 %) |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative No significant increase in frequency of miconuclei
Substance is not clastogenic in a mouse micronucleas test at dose levels of 1250, 2500 and 5000 mg/kg bw. - Executive summary:
Substance was tested in a mouse bone marrow micronucleus test according to OECD 474.
Substance is not clastogenic in this test at dose levels of 1250, 2500 and 5000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.